Abstract:Alzheimer's disease (AD), the most common cause of dementia in the elderly, has two pathological hallmarks: Aβ plaques and aggregation of hyperphosphorylated tau (p-tau). Aβ is a cleavage product of Amyloid Precursor Protein (APP). Presenilin 1 (PS1) and presenilin 2 (PS2) are the catalytic subunit of γ-secretase, which cleaves APP and mediates Aβ production. Genetic mutations in APP, PSEN1 or PSEN2 can lead to early onset of familial AD (FAD). Although mutations in the tau encoding gene MAPT leads to a subtype of frontotemporal dementia and these mutations have been used to model AD tauopathy, no MAPT mutations have been found to be associated with AD.To model AD pathophysiology in mice without the gross overexpression of mutant transgenes, we created a humanized AD mouse model by crossing the APP and PSEN1 FAD knock-in mice with the htau mice which express wildtype human MAPT genomic DNA on mouse MAPT null background (APP/PS1/htau). The APP/PS1/htau mice displayed mild, age-dependent, Aβ plaques and tau hyperphosphorylation, thus successfully recapitulating the late-onset AD pathological hallmarks. Selected biochemical analyses, including p-tau western blot, γ-secretase activity assay, and Aβ ELISA, were performed to study the interaction between Aβ and p-tau. Subsequent behavioral studies revealed that the APP/PS1/htau mice showed reduced mobility in old ages and exaggerated fear response. Genetic analysis suggested that the fear phenotype is due to a synergic interaction between Aβ and p-tau, and it can be completely abolished by tau deletion.The APP/PS1/htau model represents a valuable and disease-relevant late-onset pre-clinical AD animal model because it incorporates human AD genetics without mutant protein overexpression. Analysis of the mice revealed both cooperative and independent effects of Aβ and p-tau.

Establishment of a Drosophila AD Model

Studying Alzheimer’s Disease Using &lt;i&gt;drosophila Melanogaster&lt;/i&gt; As a Powerful Tool

Drosophila Model Of Alzheimer'S Amyloidosis

Depletion of ESCRT Ameliorates APP-induced AD-like Symptoms in Drosophila

Behavioural Effects and RNA-seq Analysis of Aβ42-Mediated Toxicity in a Drosophila Alzheimer's Disease Model

MicroRNA Expression Analysis of Adult-onset Drosophila Alzheimer’s Disease Model

Using Drosophila amyloid toxicity models to study Alzheimer's disease

Dissecting the Pathological Effects of Human Aβ40 and Aβ42 in Drosophila : A Potential Model for Alzheimer's Disease

Regulation of Sleep Behavior by Overexpression of Amyloid Precursor Protein in Drosophila Neurons

A Novel Drosophila Model of Alzheimer's Disease to Study Aβ Proteotoxicity in the Digestive Tract

Exploring the Efficient Natural Products for Alzheimer’s Disease Therapy Via Drosophila Melanogaster (fruit Fly) Models

Loss of Polo Ameliorates APP-induced Alzheimer's Disease-Like Symptoms in Drosophila.

Differential gene expression by RNA-seq during Alzheimer's disease-like progression in the Drosophila melanogaster model

An App knock-in rat model for Alzheimer’s disease exhibiting Aβ and tau pathologies, neuronal death and cognitive impairments

Dissecting The Pathological Effects Of Human A Beta 40 And A Beta 42 In Drosophila: A Potential Model For Alzheimer'S Disease

APP Physiological and Pathophysiological Functions: Insights from Animal Models

Modeling Alzheimer’s Disease in Mouse without Mutant Protein Overexpression: Cooperative and Independent Effects of Aβ and Tau

APP mouse models for Alzheimer's disease preclinical studies

FoxO Mediates APP-induced AICD-dependent Cell Death and Locomotion Defect in Drosophila AD Model

Expression of beta-amyloid induced age-dependent presynaptic and axonal changes in Drosophila

<i>CHIP</i> modulates APP-induced autophagy-dependent pathological symptoms in <i>Drosophila</i>